Key numbers here is we are on track for $10m revenue for the year and a current MC of $10m.
The April upgraded license was discussed in a stock head article where the CEO spoke of $8m in orders already over the last 2 months. "we have been inundated with client and manufacturing orders "
Ann: BXN Signs Collaboration Agreement with Cy Biopharma AG, page-4
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BXN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
-0.001(16.7%) |
Mkt cap ! $10.23M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.6¢ | 0.5¢ | $36.10K | 7.183M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 391556 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 1473902 | 5 |
View Market Depth
| Last trade - 12.18pm 26/07/2024 (20 minute delay) ? |
| BXN (ASX) Chart |